Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

NEO-HYDELTRASOL

NEOMYCIN SULFATE; PREDNISOLONE SODIUM PHOSPHATE

Standard Dose
EQ 3.5MG BASE/GM;EQ 0.25% PHOSPHATE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NEO-HYDELTRASOL is listed in Drugs@FDA under application 050378 (NDA).

Marketing status: Discontinued Active ingredient NEOMYCIN SULFATE; PREDNISOLONE SODIUM PHOSPHATE Form and strength OINTMENT;OPHTHALMIC - EQ 3.5MG BASE/GM;EQ 0.25% PHOSPHATE Sponsor MERCK Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview NEO-HYDELTRASOL is listed in Drugs@FDA under application 050378 (NDA). Marketing status: Discontinued Active ingredient NEOMYCIN SULFATE; PREDNISOLONE SODIUM PHOSPHATE Form and strength OINTMENT;OPHTHALMIC - EQ 3.5MG BASE/GM;EQ 0.25% PHOSPHATE Sponsor MERCK Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.